“SILVAMP TB LAM” Rapid Urine Tuberculosis Test Predicts Mortality in Patients Hospitalized With Human Immunodeficiency Virus in South Africa
2020 ◽
Vol 71
(8)
◽
pp. 1973-1976
◽
Keyword(s):
Abstract Reducing diagnostic delay is key toward decreasing tuberculosis-associated deaths in people living with human immunodeficiency virus. In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM (FujiLAM) could have rapidly diagnosed tuberculosis in up to 89% who died. In FujiLAM negative patients, the probability of 12-week survival was 86–97%.
Keyword(s):
2017 ◽
Vol 216
(suppl_9)
◽
pp. S824-S828
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 92
(3)
◽
pp. 636-640
◽
2019 ◽
Vol 11
(3)
◽
pp. 111